Information Provided By:
Fly News Breaks for February 10, 2020
Feb 10, 2020 | 09:29 EDT
Susquehanna analyst Don Carson raised his price target on FMC Corporation to $126 from $115 as he shifted his valuation to 2021 EBITDA estimates. He continues to see top-line growth driven by the company's diamide insecticide portfolio which should leverage the aforementioned cost tailwinds. Carson reiterated his Positive rating on FMC Corporation shares.
News For FMC From the Last 2 Days
Aug 5, 2021 | 08:21 EDT
Wells Fargo analyst Michael Sison lowered the firm's price target on FMC Corporation to $115 from $133 and keeps an Overweight rating on the shares. The analyst believes the disappointing 2021 outlook is discounted into the shares, and the inflationary pressures have been seen in other areas in his chemicals universe. What keeps him positive near-term is the potential for double-digit organic volume growth in the second half of 2021 - anchored by a seasonally stronger Q4, with Brazil fundamentals positive and MSD organic volume growth in 2022, which in total would confirm his belief that its growth model is still thriving.
Aug 5, 2021 | 07:33 EDT
BMO Capital analyst Joel Jackson lowered the firm's price target on FMC Corporation to $120 from $130 and keeps an Outperform rating on the shares after its FY21 guidance cut. The analyst states that it is no longer clear that FMC represents "predictable and solid" growth for premium ag/materials exposure, as competitive pressures seem to be rendering it harder than in the past for the company to fully offset cost inflation and FX via price coverage/pass-through.
Aug 3, 2021 | 16:37 EDT
Prior view was $1.32B-$1.42B. Cuts FY free cash flow forecast to $480M-$570M from $530M-$620M. Expects to repurchase $350M-$450M of FMC shares in 2021 vs. prior view of $400M-$500M.
Aug 3, 2021 | 16:34 EDT
FY21 consensus $7.12. Backs FY21 revenue view $4.9B-$5.1B, consensus $4.99B.